封面
市場調查報告書
商品編碼
2149641

內視鏡止血裝置市場規模、細分、佔有率、監管、保險償付、介入措施及至2034年的預測

Endoscopic Hemostasis Devices Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036

出版日期: | 出版商: GlobalData | 英文 | 訂單完成後即時交付

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

本報告《內視鏡止血裝置市場規模、細分、佔有率、監管、保險償付、介入措施及至2034年的預測》目的是可視化內視鏡設備治療領域的定量和定性市場趨勢。

內視鏡止血裝置包括用於處理胃腸道出血的器械,通常作為第一線治療方法。內視鏡止血裝置一般分為機械裝置(止血夾、結紮器、縫合器、支架)、注射裝置(注射針)、熱能裝置(止血探針、止血鉗、加熱探針、氬等離子凝固術、射頻消融術、冷凍法)及局部裝置(止血噴霧劑)。

內視鏡止血術是一種用於治療消化道出血的技術,通常作為第一線治療方法。內視鏡止血術的適應症包括多種上消化道和下消化道出血。上消化道出血主要包括消化性潰瘍出血和食道靜脈曲張出血,而下消化道出血最常見的住院原因是憩室出血和良性肛門直腸出血。

針對39個目標國家,建構了基於引用資料、採用顏色編碼的市場模型,其中包含流行病學指標和治療人數。互動式Excel格式的交付成果包括貨幣價值、病例數、產品使用情況、平均售價、市場規模和企業市場占有率分析(如有)。此外,分析師的評論,包括定性見解,為定量資料提供了背景資訊。

市場模型的主要組成部分:

目前可用的內視鏡止血裝置及不斷變化的競爭格局:

  • 對關鍵行業趨勢的深刻評論
  • 2015年至2036年內視鏡止血器材各細分市場的年度總銷售額及市場前景。
  • 依細分市場分類的手術總數、銷售單位、平均售價和市場價值的詳細資料。

對全球、區域和特定國家市場的具體見解:

  • 除了針對特定市場的定性資訊外,還提供全球趨勢細分為區域趨勢的更詳細分析。此外,GlobalData 分析師還將提供獨特的、針對特定國家的市場洞察。
  • 內視鏡止血裝置市場SWOT分析
  • 內視鏡止血裝置市場競爭考察及趨勢

透過獲得真正全面的概覽,包括對醫療保健系統的概述,可以加深對市場的理解。此外,在「市場進入」部分,可以利用有關償付政策和監管條件的資訊,更深入地了解市場動態。

  • 各國醫療保健系統概覽
  • 各國具體的還款政策
  • 各國醫療設備法規

憑藉可靠的調查方法和資料來源,該模型能夠提供全面且準確的市場概覽。來自需求方和供應方(包括關鍵意見領袖)的第一手資訊均整合到企業聯合組織模型中。此外,該模型還利用真實世界的資料來源來捕捉市場趨勢,包括政府手術資料庫、醫院採購資料庫和專有線上資料庫。

目標公司:Boston Scientific Corp、ConMed Corp、Wilson-Cook Medical Inc、ERBE Elektromedizin GmbH、Olympus Corp、United States Endoscopy Group Inc、Micro-Tech Nanjing Co Ltd、Integra LifeSciences Holdings Corp、Medline Industries LP、Diversatek Inc等。

目標國家:美國、英國、德國、法國、義大利、西班牙、巴西、中國、印度、俄羅斯、日本、澳洲、加拿大、墨西哥、韓國、丹麥、愛爾蘭、荷蘭、紐西蘭、南非、瑞典、瑞士、奧地利、比利時、芬蘭、以色列、挪威、波蘭、葡萄牙、台灣、捷克、希臘、匈牙利、土耳其、埃及、沙烏地阿拉伯、阿拉伯聯合大公國、阿根廷、智利

調查範圍

這個市場模型提供了其他任何資訊來源都無法獲得的關鍵專家見解。它揭示了目標市場的定性和定量趨勢。以下人群必須閱讀此模型:

  • 行銷長(CMO)要製定策略計畫和投資決策,必須深入了解內視鏡止血市場。
  • 採購主管需要了解供應基礎的關鍵要素,以便做出有關供應商選擇和管理的決策。
  • 私募股權投資者需要對市場有更深入的了解,才能發現潛在的投資機會並評估其價值。

購買原因

這將使該模型的應用成為可能。

  • 透過識別關鍵公司並仔細審查研發線產品,可以製定和設計引進和引進許可策略。
  • 可以了解影響和驅動內視鏡止血設備市場的趨勢,並制定商業策略。
  • 透過了解關鍵趨勢、創新產品和技術、市場細分以及未來可能影響內視鏡止血設備市場的公司,可以增加收入。
  • 透過了解競爭格局並分析領導企業的市場佔有率,可以製定有效的銷售和行銷策略。
  • 尋找具有強大產品系列潛力的新興企業,並制定有效的應對策略以獲得競爭優勢。
  • 本報告追蹤了2015年至2036年全球及各國內鏡止血裝置的銷售趨勢。
  • 確定在整合、投資和策略聯盟方面提供最大機會的市場類別和細分市場,並據此系統化銷售和行銷活動。
簡介目錄
Product Code: GDME717MM

Endoscopic Hemostasis Devices Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 is built to visualize quantitative and qualitative market trends within Endoscopy Devices therapeutic area.

Endoscopic Hemostasis Devices consists of devices employed in the management of Gastrointestinal (GI) bleeding and often acts as the first line of therapy. Endoscopic Hemostasis Devices are generally classified into mechanical devices (clips, ligation devices, suturing devices, stents), injection devices (injection needles), thermal devices (hemostatic probes, hemostatic forceps, heater probe, argon plasma coagulation, radiofrequency ablation, and cryotherapy) and topical devices (hemostatic spray).

Endoscopic Hemostasis is a technique employed in the management of Gastrointestinal (GI) bleeding and often acts as the first line of therapy. The indications of endoscopic hemostasis technique include various upper and lower gastrointestinal bleeding diseases. Upper GI bleeding mainly includes peptic ulcer bleeding and variceal bleeding while diverticular bleeding and benign anorectal bleeding are the most common etiologies for hospital admissions with lower GI bleeding.

Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with intervention volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are:

Currently marketed Endoscopic Hemostasis Devices and evolving competitive landscape:

  • Insightful review of the key industry trends.
  • Annualized total Endoscopic Hemostasis Devices market revenue by segment and market outlooks from 2015-2036.
  • Granular data on total Interventions, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights:

  • Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
  • SWOT analysis for Endoscopic Hemostasis Devices market.
  • Competitive dynamics insights and trends provided for Endoscopic Hemostasis Devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Boston Scientific Corp, ConMed Corp, Wilson-Cook Medical Inc, ERBE Elektromedizin GmbH, Olympus Corp, United States Endoscopy Group Inc, Micro-Tech Nanjing Co Ltd, Integra LifeSciences Holdings Corp, Medline Industries LP, Diversatek Inc, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

  • CMO executives who must have deep understanding of the Endoscopic Hemostasis market place to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
  • Develop business strategies by understanding the trends shaping and driving Endoscopic Hemostasis Devices market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Endoscopic Hemostasis Devices market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific Endoscopic Hemostasis Devices market from 2015-2036.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.